FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

DR AGARWALS EYE HOSPITAL LTD.

NSE : NABSE : 526783ISIN CODE : INE934C01018Industry : Hospital & Healthcare ServicesHouse : Private

BSE5540.9543.25 (+0.79 %)

PREV CLOSE (Rs.) 5497.70

OPEN PRICE (Rs.) 5497.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 773

TODAY'S LOW / HIGH (Rs.)5495.05 5547.95

52 WK LOW / HIGH (Rs.) 35007300

NSE

This Company is not listed in NSE

More From Company Profile

Smart Quotes

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

42.82

Dividend Yield(%)

0.11

TTM EPS (Rs.)

130.30

P/E Ratio

42.53

Book Value (Rs.)

650.91

Face Value (Rs.)

MCap (Rs. in Mn)

26778.45

Price/Earning (TTM)

25.48

Price/Sales (TTM)

6.23

Price/Book (MRQ)

8.51

PAT Margin (%)

13.76

ROCE (%)

33.26

Incorporation Year : 22-04 1994

Management Info :

Amar Agarwal - Chairman Amar Agarwal - Managing Director

Registered Office :

Address : 3rd Floor, Buhari Towers, No.4, Moores Road,Off. Greams Road,Near Asan Memorial School,
Chennai,
Tamil Nadu-600006

Phone : 044-43787777 / 78

Email : info@dragarwal.com

Website : www.dragarwal.com

Registrars Details :

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai

Listing : BSE

NEWS

27Oct Dr. Agarwal’s Eye Hospital informs abo
In furtherance to letter dated October 22, 2025, Dr. Agarwal’s Eye Hospi..

19Mar Dr Agarwals Eye Hospital commences ope
Dr Agarwals Eye Hospital has commenced operation of a new branch located..

30Sep Dr. Agarwal’s Eye Hospital informs abo
As per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and t..

Financials

	QTR Sep 25	ANNUAL 25
Net Profit	193.2	546.5
Gross Profit	257.2	707
Operating Profit	407.6	1235.9
Net Sales	1177.2	3971.5

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)

7101.80 (1.31%)

M.Cap (Rs. in Cr)102112.99

Jupiter Life Line (BSE)

1419.85 (1.35%)

M.Cap (Rs. in Cr)9309.39

Fortis Healthcare (BSE)

874.30 (2.12%)

M.Cap (Rs. in Cr)66005.99

Indraprastha Medical (BSE)

471.75 (3.30%)

M.Cap (Rs. in Cr)4324.67

Shareholding Pattern

	PROMOTERS	72.67%
	NON-INSTITUTION	23.23%
	MUTUAL FUNDS/UTI	0.18%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

WOC Pharma and Heal...

0.62

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22